LumiraDx Limited Warrant
LMDXW
LMDXW was delisted on the 8th of January, 2024.
15 hedge funds and large institutions have $2.76M invested in LumiraDx Limited Warrant in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
12% less funds holding
Funds holding: 17 → 15 (-2)
46% less capital invested
Capital invested by funds: $5.16M → $2.76M (-$2.39M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$121 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
-$855 |
| 2 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$19 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVS Health
Woonsocket,
Rhode Island
| $2.49M | – | – | – |
|
|
SM
2
Senvest Management
New York
| $124K | – | – | – |
|
|
LP
3
LMR Partners
London,
United Kingdom
| $93.3K | – | – | – |
|
4
Balyasny Asset Management
Chicago,
Illinois
| $20.9K | – | – | – |
|
|
KL
5
KIM LLC
Wichita,
Kansas
| $10.6K | – | – | – |
|
|
MI
6
MMCAP International
Grand Cayman,
Cayman Islands
| $5.04K | – | – | – |
|
|
MCM
7
Moore Capital Management
New York
| $4.93K | – | – | – |
|
8
Walleye Capital
New York
| $3.52K | – | – | – |
|
|
CP
9
Covalent Partners
Concord,
Massachusetts
| $3.23K | – | – | – |
|
|
WAM
10
Wolverine Asset Management
Chicago,
Illinois
| $2.8K | +$121 | +1,433 | +6% |
|
11
Walleye Trading
New York
| $2.35K | – | – | – |
|
|
AA
12
Ancora Advisors
Cleveland,
Ohio
| $2.17K | -$19 | -230 | -0.9% |
|
|
CAM
13
Cresset Asset Management
Chicago,
Illinois
| $1.62K | – | – | – |
|
|
BTP
14
Bloom Tree Partners
New York
| $872 | – | – | – |
|
15
Morgan Stanley
New York
| $224 | – | – | – |
|
|
CAC
16
Cowen and Company
New York
| – | -$855 | -14,495 | Closed |
|
LMDXW Hedge Fund Activity: Q1 2023 in Review
15 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in LumiraDx Limited Warrant (LMDXW) for Q1 2023, worth a combined $2.76M — down 46% from $5.16M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of LMDXW and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Wolverine Asset Management, adding an estimated $121. The largest seller was Cowen and Company, exiting entirely with an estimated $855 sold.
- 15 institutional investors held LumiraDx Limited Warrant (LMDXW) as of Q1 2023, down from 17 in Q4 2022.
- Funds reported $2.76M of LumiraDx Limited Warrant stock for Q1 2023, down 46% quarter-over-quarter.
- 0 funds opened new LumiraDx Limited Warrant positions in Q1 2023 and 2 closed out, a net change of -2 holders.
- The largest LumiraDx Limited Warrant buyer in Q1 2023 was Wolverine Asset Management, an estimated $121 added.
- The largest LumiraDx Limited Warrant seller in Q1 2023 was Cowen and Company, an estimated $855 sold.
Based on aggregated 13F filings for Q1 2023.